Viatris Inc false 0001792044 --12-31 0001792044 2023-12-14 2023-12-14

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 14, 2023

 

 

VIATRIS INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-39695   83-4364296

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

1000 Mylan Boulevard, Canonsburg, Pennsylvania, 15317

(Address of Principal Executive Offices)

Registrant’s telephone number, including area code: (724) 514-1800

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, par value $0.01 per share   VTRS   The NASDAQ Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 5.03

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On December 14, 2023, the Board of Directors (the “Board”) of Viatris Inc. (“Viatris” or the “Company”) approved the Amended and Restated Bylaws of Viatris Inc. (the “Amended and Restated Bylaws”), which became effective immediately after the 2023 annual meeting of shareholders (the “2023 Annual Meeting”). Among other things, the Amended and Restated Bylaws:

 

   

As a result of the effectiveness of rules related to the use of “universal” proxy cards, update the procedural mechanics and disclosure requirements relating to director nominations submitted by shareholders pursuant to the advance notice provisions of the Amended and Restated Bylaws, including by:

 

   

requiring that any shareholder submitting such a nomination provide certain representations regarding engaging in a solicitation with respect to its nomination and to provide certain related documentation and confirmations with respect to Rule 14a-19 promulgated under the Securities Exchange Act of 1934, as amended (i.e., federal proxy rules regarding the use of “universal” proxy cards in contested director elections);

 

   

requiring that any shareholder soliciting proxies in accordance with its representations with respect to Rule 14a-19 notify the Company of any change in such intent within two business days;

 

   

limiting the number of nominees a shareholder may nominate for election at a shareholder meeting to the number of directors to be elected at such meeting;

 

   

clarifying how votes are treated by the Company in the event proxies for disqualified or withdrawn nominees for the Board are received; and

 

   

requiring that a shareholder directly or indirectly soliciting proxies from other shareholders use a proxy card color other than white.

 

   

As a result of recent amendments to the Delaware General Corporation Law, clarify certain procedures regarding shareholder meetings, including with respect to meeting place, adjournment and meeting notices, meeting conduct and shareholder lists, among other updates.

Additional amendments were made to make clarifying or conforming language changes, in addition to technical or ministerial changes. The foregoing description of the Amended and Restated Bylaws does not purport to be complete and is subject to, and qualified in its entirety by reference to, the full text of the Amended and Restated Bylaws, which are attached as Exhibit 3.1 hereto and incorporated herein by reference.

 

Item 5.07

Submission of Matters to a Vote of Security Holders.

(a)    On December 15, 2023, Viatris held the 2023 Annual Meeting to (i) elect eleven director nominees, each to hold office until the 2024 annual meeting of shareholders; (ii) approve, on a non-binding advisory basis, the 2022 compensation of the named executive officers of the Company; (iii) ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023; (iv) approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to add a federal forum selection provision; and (v) approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation. With respect to Proposals 1 through 3 below, any abstentions and broker non-votes were considered for purposes of establishing a quorum but were not considered to be votes cast and therefore had no effect on the vote on any such proposal. With respect to Proposals 4 and 5 below, any abstentions and broker non-votes were considered for purposes of establishing a quorum but had the same effect as a vote against such proposal.

 

(b)

The certified results of the matters voted on at the 2023 Annual Meeting are set forth below.

Proposal No. 1 - Election of the following eleven director nominees, each to hold office until the 2024 annual meeting of shareholders:

 

Nominee

   For    Against    Abstain    Broker Non-Votes

W. Don Cornwell

   866,064,217    12,641,904    2,928,374    129,071,354

JoEllen Lyons Dillon

   737,415,797    141,442,673    2,776,030    129,071,350

Elisha W. Finney

   858,566,340    20,133,375    2,894,785    129,111,349

Leo Groothuis

   872,997,150    5,758,236    2,876,110    129,074,353

Melina Higgins

   823,591,802    55,258,023    2,784,503    129,071,520

James M. Kilts

   822,629,367    56,144,991    2,860,131    129,071,359

Harry A. Korman

   773,082,826    105,601,971    2,849,699    129,171,353

Rajiv Malik

   791,020,816    87,750,089    2,863,590    129,071,354

Richard A. Mark, C.P.A.

   867,190,829    11,613,601    2,829,062    129,072,357

Mark W. Parrish

   833,335,130    45,420,155    2,879,204    129,071,360

Scott A. Smith

   871,110,883    7,619,635    2,903,975    129,071,356

Each director nominee was elected to hold office until the 2024 annual meeting of shareholders.


Proposal No. 2 – Approval, on a non-binding advisory basis, of the 2022 compensation of the named executive officers of the Company:

 

For

 

Against

 

Abstain

 

Broker Non-Votes

751,056,625   125,615,255   4,962,588   129,071,382

This proposal was approved.

Proposal No. 3 – Ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023:

 

For

 

Against

 

Abstain

 

Broker Non-Votes

951,005,898   55,389,016   4,310,936   N/A

This proposal was approved.

Proposal No. 4 – Approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation to add a federal forum selection provision:

 

For

 

Against

 

Abstain

 

Broker Non-Votes

775,943,332   101,876,413   3,774,593   129,111,511

This proposal was approved.

Proposal No. 5 – Approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation:

 

For

 

Against

 

Abstain

 

Broker Non-Votes

712,407,131   165,367,429   3,861,922   129,069,367

This proposal was approved.

 

Item 9.01

Financial Statements and Exhibits.

(d)     Exhibits.

 

Exhibit

    No.    

   Description
3.1    Amended and Restated Bylaws of Viatris Inc., effective as of December 15, 2023.
104    Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIATRIS INC.
Date: December 15, 2023     By:  

/s/ Brian Roman

      Brian Roman
      Global General Counsel